Available space and objects
The former convalescent home is one of the five major hospitals and patient care institutions, which Ludwig Hoffmann designed for the Buch location at the beginning of the 20th century. Avenues, extensive green spaces and garden courtyards give the heritage-protected ensemble an ambience of spaciousness and a clear structure. Besides representative, almost palatial buildings, there are also residential buildings in country house style. Moreover, modern, functional buildings and areas for the construction of new buildings are available. Around two thirds of all individual projects, including 500 apartments, schools, daycare centers, childcare facilities and a sports hall, have already been handed over and are in use. After the planned completion, 1,000 apartments will have been built in the Ludwig Hoffmann Quartier.
| Owner and builder: | Ludwig-Hoffmann-Quartier Objektgesellschaft mbH & Co KG |
| Project developer: | SITUS GmbH Grundstück & Projekt |
| Address: | Wiltbergstraße 50, 13125 Berlin-Buch |
| Property area: | 28 Hektar |
| Gross floor space: | 125,000 m² |
| of this, area that is heritage-protected: | 110,000 m² |
| Number of individual projects: | 36 |
| Planned use: | residential, commercial, education |
| Start of construction: | 2012 |
| Completion: | anticipated for 2027 |
360°-panoramas of the Quartier: www.l-h-q.de/virtuelle-tour-lhq
Virtual tour of the Ludwig-Hoffmann-Quartier
www.ludwig-hoffmann-quartier.de
BiotechPark Berlin-Buch
Berlin-Buch, with its long tradition of excellent biomedical basic and clinical research as well as clinical expertise, is an ideal environment for life science companies. The campus atmosphere is conducive to scientific exchange, technology transfer and collaborative projects.
With an area of approximately 45,000 m², the BiotechPark Berlin-Buch is one of the largest biotech parks in Germany. Here entrepreneurs and companies find affordable, industry-specific laboratory and office space with state-of-the-art facilities. Start-ups can grow and thrive in the Innovation and Incubation Center, building areas on the Campus allow for future development. The managing company, Campus Berlin-Buch GmbH, supports the companies in all matters and provides comprehensive service.
Currently, approximately 75 companies are located on campus and employ around 850 people. More than 50 of these companies are in the biotech sector, several others offer services for the life science industry. Since 1998 the number of employees of the biotech companies has more than doubled.
The business fields of the companies range from medical technology products, molecular biological diagnostics and treatments, preclinical pharmacological and pharmacogenomic tests, RNA technologies, the search for pharma-relevant target molecules, production and testing of drugs and the analysis and synthesis of biomolecules.
Link to the real estate portal:
www.campusberlinbuch.de/en/immobilien
Link to the new start-up center BerlinBioCube:
News Buch Berlin
A fresh take on proteomics
Start-up company Absea Biotechnology GmbH is developing new proteomics technologies. An interview with Dr. Philip Lössl, Senior VP Science and Business Development
more ...A double-pronged attack on malignant B cells
Multiple myeloma, a cancer of the bone marrow, remains difficult to treat despite modern CAR T cell therapies. In “Molecular Therapy,” a team led by Armin Rehm presents an improved immunotherapy that ...
more ...A new opportunity for Berlin
The Einstein Center for Early Disease Interception has been funded with six million euros. In an interview, Nikolaus Rajewsky and Leif Erik Sander, both spokespeople of the center, explain why new tec...
more ...Events Buch Berlin
26.01.2026, 16:00
Einfach Wissen: Desinformation als Strategie? Neue Spielarten politischen Handelns im digitalen Raum
Im Auftakt der neuen Reihe "Einfach Wissen" von rbb24 und der Technologiestiftung Berlin zeigt Prof. Dr. Jeanette Hofmann, welche Rolle Falschinformationen bei denjenigen spielen, die sich von der Dem...
more ...28.01.2026, 16:00
Labor trifft Lehrer*in: Wie Hirnorganoide helfen, Therapien für Neuroentwicklungs- krankheiten zu entwickeln
Vortrag von Jakob Metzger, Max Delbrück Center: Seltene genetische Veränderungen können die Entwicklung des menschlichen Gehirns tiefgreifend beeinflussen und neurologische Erkrankungen verursachen – ...
more ...28.01.2026, 17:00
"Musik trifft Wissenschaft" Bucher Campus-Klassikkonzert
mit den Pianisten Tabea und Daniel Streicher, die Werke von Ravel, Bartok, Bach u.a. spielen
more ...